When pregnancy is detected, consider alternatives and discontinue Entresto. However, if there is no appropriate alternative therapy with drugs affecting the renin-angiotensin system, and if the ...

Novartis’ Entresto is on course to become the first drug to be approved in the US for a form of heart failure that is notoriously hard to treat effectively, despite missing the mark in a phase 3 ...

As the ink dries on the US approval of Novartis' heart failure treatment Entresto, talk has quickly shifted to pricing issues, and possible outcomes-based plans, rather than the drug's very ...

The Anthos Therapeutics acquisition represents a homecoming for its drug abelacimab, which originated in Novartis’s labs.

Have you been prescribed Entresto or Jardiance? Deep discounts on Medicare drugs coming ...

Novartis' Entresto is a drug approved for the treatment of heart failure with reduced ejection fraction. Entresto has the potential to gradually reverse the damage to the heart's structure and ...

The deal underlines the Swiss group's commitment to cardiovascular therapies, one of five medical areas that it is focusing on, as its best-selling heart failure drug Entresto loses patent ...

Heart failure drug Entresto sales grew 34% at constant currency, driven by strong demand and greater market share in the U.S. and Europe for heart failure treatment. It also saw increased use in ...